- Home
- NAGE vs TPVG Comparison
NAGE vs TPVG Comparison
Compare NAGE & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAGE | TPVG |
|---|---|---|
| Founded | 1999 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 174.6M |
| IPO Year | 2010 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NAGE | TPVG |
|---|---|---|
| Price | $2.07 | $3.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $10.67 | $5.67 |
| AVG Volume (30 Days) | ★ 518.4K | 232.8K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 23.41% |
| EPS Growth | ★ 81.82 | N/A |
| EPS | 0.07 | ★ 0.59 |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.79 | $0.69 |
| P/E Ratio | $30.50 | ★ $6.70 |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.04 | $3.95 |
| 52 Week High | $7.12 | $6.95 |
Technical Indicators
Market Signals| Indicator | NAGE | TPVG |
|---|---|---|
| Relative Strength Index (RSI) | 35.09 | 30.15 |
| Support Level | $2.04 | N/A |
| Resistance Level | $3.61 | $4.88 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 5.41 | 6.02 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the firm's operations are located across the United States.